Eikonizo Therapeutics Company Overview, Contact Details & Competitors

Q: What is Eikonizo Therapeutics's official website and social media links?

Eikonizo Therapeutics's official website is eikonizo.com. Eikonizo Therapeutics has social profiles on LinkedIn.

Q: How many employees does Eikonizo Therapeutics have currently?

Eikonizo Therapeutics has approximately 14 employees.

Q: What technology does Eikonizo Therapeutics use?

Eikonizo Therapeutics's tech stack includes HTTP/3, Google Maps, OceanWP, WordPress, Lightbox.

Insights

Gathering insights about Eikonizo Therapeutics…

Similar companies to Eikonizo Therapeutics

Eikonizo Therapeutics Tech Stack

Eikonizo Therapeutics uses 8 technology products and services including oEmbed, Google Workspace, Lightbox, and more. Explore Eikonizo Therapeutics's tech stack below.

oEmbed
Dev Tools
Google Workspace
Email
Lightbox
Javascript Libraries
imagesLoaded
Javascript Libraries
reCAPTCHA
Security
HSTS
Security
OceanWP
Web Platform Extensions
Nginx
Web Servers

Media & News

Eikonizo Therapeutics, Inc hires Bill Haynes as Professor.
Concurrent with its investment, Miriam Frieden, Novo Nordisk's Corporate Vice President of Early Innovation, Outreach and Alliances will join Eikonizo's Board of Directors as a non-voting observer and Professor Bill Haynes, Scientific Corporate Vice President, Global Drug Discovery, Novo Nordisk, will join Eikonizo's Scientific Advisory Board.
Dec 10, 2024 | pipelinereview.com
Eikonizo Therapeutics, Inc hires Jon Graves.
Eikonizo also announced key additions to strengthen its leadership with the appointment of Thomas E. Hughes, PhD, Chairperson and Chief Executive Officer of Navitor Pharmaceuticals, to its Board of Directors, as well as Richard A. Fisher, PhD, as Chief Scientific Officer, Jim Luterman, PhD, as Executive Vice President of Development and Jon Graves, CPA as Vice President, Finance and Controller.
Dec 10, 2024 | www.contractpharma.com
Eikonizo Therapeutics, Inc hires Miriam Frieden as scientific corporate vice president, global drug Discovery.
Concurrent with its investment, Miriam Frieden, Novo Nordisk's corporate vice president of early innovation, outreach and alliances, will join Eikonizo's board of directors as a non-voting observer and Professor Bill Haynes, scientific corporate vice president, global drug Discovery, Novo Nordisk, will join Eikonizo's scientific advisory board.
Dec 10, 2024 | www.thepharmaletter.com
Novo Nordisk A/S invested into Eikonizo Therapeutics, Inc on Dec 10th '24.
Eikonizo Therapeutics, Inc. announced that it has received funding from Novo Nordisk A/S.
Dec 09, 2024 | www.marketscreener.com
Eikonizo Therapeutics, Inc received financing of $12M in Series A on Sep 24th '19.
Eikonizo, which has operated quietly until now, is in the process of raising up to $12 million in Series A funding to move its therapeutic drug toward initial clinical trials, co-founder and Chief Executive Janice Kranz said.
Sep 23, 2019 | www.wsj.com

Eikonizo Therapeutics's Email Address Formats

Eikonizo Therapeutics uses at least 1 format(s):

Eikonizo Therapeutics Email Formats	Example	Percentage
First.Last@eikonizo.com	John.Doe@eikonizo.com	48%
First.Middle@eikonizo.com	John.Michael@eikonizo.com	2%
First.Last@eikonizo.com	John.Doe@eikonizo.com	48%
First.Middle@eikonizo.com	John.Michael@eikonizo.com	2%

Frequently Asked Questions

Where is Eikonizo Therapeutics's headquarters located?

Eikonizo Therapeutics's main headquarters is located at 700 Main Street North, Cambridge, MA 02139 , US. The company has employees across 1 continents, including North America.

What is Eikonizo Therapeutics's official website and social media links?

Eikonizo Therapeutics's official website is eikonizo.com and has social profiles on LinkedIn Crunchbase.

What is Eikonizo Therapeutics's SIC code NAICS code?

Eikonizo Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eikonizo Therapeutics have currently?

As of October 2025, Eikonizo Therapeutics has approximately 14 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: R. F.Chief Scientific Officer: R. F.Vp Finance And Controller: J. G.. Explore Eikonizo Therapeutics's employee directory with LeadIQ.

What industry does Eikonizo Therapeutics belong to?

Eikonizo Therapeutics operates in the Biotechnology Research industry.

What technology does Eikonizo Therapeutics use?

Eikonizo Therapeutics's tech stack includes oEmbedGoogle WorkspaceLightboximagesLoadedreCAPTCHAHSTSOceanWPNginx.

What is Eikonizo Therapeutics's email format?

Eikonizo Therapeutics's email format typically follows the pattern of First.Last@eikonizo.com. Find more Eikonizo Therapeutics email formats with LeadIQ.

When was Eikonizo Therapeutics founded?

Eikonizo Therapeutics was founded in 2017.

Insights

Similar companies to Eikonizo Therapeutics

Boundless Bio

Relay Therapeutics

Black Diamond Therapeutics

Celsius Therapeutics

Civetta Therapeutics

Skyhawk Therapeutics

Gotham Therapeutics

Petra Pharma Corporation

Arbor Biotechnologies

Eikonizo Therapeutics Tech Stack

Media & News

Eikonizo Therapeutics, Inc hires Bill Haynes as Professor.

Eikonizo Therapeutics, Inc hires Jon Graves.

Eikonizo Therapeutics, Inc hires Miriam Frieden as scientific corporate vice president, global drug Discovery.

Novo Nordisk A/S invested into Eikonizo Therapeutics, Inc on Dec 10th '24.

Eikonizo Therapeutics, Inc received financing of $12M in Series A on Sep 24th '19.

Eikonizo Therapeutics's Email Address Formats

Frequently Asked Questions

Where is Eikonizo Therapeutics's headquarters located?

What is Eikonizo Therapeutics's official website and social media links?

What is Eikonizo Therapeutics's SIC code NAICS code?

How many employees does Eikonizo Therapeutics have currently?

What industry does Eikonizo Therapeutics belong to?

What technology does Eikonizo Therapeutics use?

What is Eikonizo Therapeutics's email format?

When was Eikonizo Therapeutics founded?

Eikonizo Therapeutics

Company Overview

Media & News

Eikonizo Therapeutics, Inc hires Bill Haynes as Professor.

Eikonizo Therapeutics, Inc hires Jon Graves.

Eikonizo Therapeutics, Inc hires Miriam Frieden as scientific corporate vice president, global drug Discovery.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?